What is the main topic?

The article discusses Novo Nordisk's potential exposure to tariffs imposed by the Trump administration on the EU and its business outlook.

How is Novo Nordisk responding to the tariff threat?

Novo Nordisk's CEO expressed confidence in the company's business positioning despite the potential tariffs.

Where did the CEO make the announcement?

The announcement was made at Novo Nordisk's headquarters near Copenhagen.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Headlines

Novo Nordisk Says It's Not Immune to Potential Trump Tariffs, but Business Is Well-Positioned

Published by Global Banking & Finance Review®

Posted on February 5, 2025

1 min read

Last updated: January 26, 2026

Add as preferred source on Google

Novo Nordisk CEO Lars Fruergaard Jorgensen discussing tariff impacts - Global Banking & Finance Review — Novo Nordisk CEO Lars Fruergaard Jorgensen addresses potential tariffs from Trump and their impact on the company, showcasing confidence in business positioning amid economic challenges.

Novo Nordisk Says It's Not Immune to Potential Trump Tariffs, but Business Is Well-Positioned

Quick Summary

Novo Nordisk Faces Potential Tariffs, Stays Confident

Key Takeaways

Frequently Asked Questions about Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned